DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Tuesday reported a loss of $8.3 million in its third quarter.
On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 63 cents.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.
Zynerba shares have decreased 22 percent since the beginning of the year. The stock has decreased 11 percent in the last 12 months.